
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Referenced in this guide
Referenced in this guide
Contributed in this guide
Contributed in this guide
Figure out what Speech and Language Therapy means for you
Speech and Language Therapy protocols tailored for Parkinson’s disease primarily focus on increasing vocal loudness and clarity. A leading example is the LSVT LOUD program, pioneered by Dr. Lorraine Ramig and colleagues, which follows a standardized, high-intensity schedule targeting articulation, breath support, and consistent voice quality. By emphasizing frequent sessions and structured practice, this evidence-based method aims to address the common issue of reduced vocal amplitude in individuals with Parkinson’s while also supporting secondary benefits such as improved swallowing and a stronger ability to project speech in everyday settings.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
Hi! I just finished a speech therapy course, and I believe it has helped! Now, I try to sing out loud whenever I’m alone, like in the car or shower. In fact, I’m even having an easier time swallowing my pills. I guess it’s just another muscle that needs to be exercised!
December +54824 • Parkinsons News Today
Patient view
I have been taking speech therapy thru the Mpls VA for a year now via video link once/week and will continue with it because it has helped me.
December +53383 • Parkinsons News Today
31 expert views
Expert view
Speech and Language Therapy (SLT) is beneficial for people with Parkinson's disease at all stages, including early stages when speech, swallowing, and cognitive changes may begin. Dr. Cynthia highlights the importance of evidence-based practices, such as LSVT LOUD, which is considered the gold standard due to extensive research, including randomized controlled trials. SLT aims to improve communication, self-efficacy, and confidence, helping individuals stay engaged in life activities. The therapy involves exercises to enhance loudness and communication success, reducing withdrawal and promoting active participation.
November 2020 • The Victory Summit: Speech Therapy and Parkinson's
Expert view
Speech and Language Therapy (SLT) can help people with Parkinson's improve their speech and swallowing issues, but it requires consistent effort and practice. The therapy involves daily exercises, similar to training for singers, and can be mentally challenging. The speaker shared their experience of working with multiple speech therapists, emphasizing the importance of finding a therapist who is encouraging and diligent. They noted that while SLT may not restore speech to its original state, it can lead to noticeable improvements when practiced regularly.
October 2023 • The Parkinson's Podcast: Questions and Answers about Parkinson's
To support communication strategies.
To improve speech clarity and volume.
To address dysphagia and prevent complications.
To maintain communication skills longer.
Long-term effects of SLT on severe Parkinson's unclear.
Research
This paper investigated the effects of Speech and Language Therapy (SLT) on hypokinetic dysarthria, a speech disorder common in Parkinson's disease. Researchers conducted a systematic review and meta-analysis of 15 randomized controlled trials involving 619 patients, analyzing variables like sound pressure levels, voice inflection, and speech intelligibility.
The study found that SLT significantly improved sound pressure levels during sustained phonation tasks, reading tasks, and monologue tasks. Improvements were also noted in semitone standard deviation and perceptual intelligibility, indicating better voice modulation and clearer speech.
For individuals with Parkinson's disease, this research highlights the potential of SLT to improve communication abilities, which can enhance social interactions and overall quality of life. Caregivers may find SLT a valuable tool in managing speech-related challenges in Parkinson's patients.
This paper is highly reliable as it is a systematic review and meta-analysis, which are considered strong evidence types in research. It was published in 'Clinical Rehabilitation,' a reputable journal, and used robust methods to assess study quality and bias.
November 2020 • Clinical rehabilitation
Research
This paper analyzed the effectiveness of Speech and Language Therapies (SLTs) for voice problems in Parkinson's disease (PD) by reviewing data from 10 randomized controlled trials. The studies included 230 patients receiving SLTs and 205 patients in control groups, focusing on improvements in vocal loudness and communication abilities.
The meta-analysis found that SLTs significantly improved vocal loudness during sustained phonation, reading, and monologues, as well as reduced Voice Handicap Index scores. These benefits were observed at various intervals, including 3 months and 6 months after treatment, with some effects lasting over 12 months.
For individuals with Parkinson's disease, this study highlights that SLTs, particularly the Lee Silverman Voice Treatment, can effectively enhance vocal loudness and communication, addressing a common and challenging symptom of the condition. This can improve daily interactions and overall quality of life.
The study is reliable as it is a meta-analysis of randomized controlled trials, which are considered high-quality evidence. Published in a reputable journal, it provides a strong basis for understanding the efficacy of SLTs in Parkinson's disease.
May 2020 • The Journal of neuropsychiatry and clinical neurosciences
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto